High-purity Pinealon is essential for maintaining experimental validity and reproducibility across cell culture and animal models. This reference guide outlines the analytical benchmarks, quality control protocols, and storage parameters required for research-grade Pinealon (Glu-Asp-Arg).
High-purity Pinealon is essential for maintaining experimental validity and reproducibility across cell culture and animal models. This reference guide outlines the analytical benchmarks, quality control protocols, and storage parameters required for research-grade Pinealon (Glu-Asp-Arg).
High-purity Pinealon refers to synthetic tripeptide (Glu-Asp-Arg) verified at >98% chemical purity via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS), with certified low endotoxin levels (<0.01 EU/mg). Purity ensures experimental reproducibility by eliminating truncated peptide fragments, residual trifluoroacetic acid (TFA), and micro-contaminants in cell culture and preclinical assays.
In experimental settings, minor chemical impurities or sequence deletions can significantly alter cellular binding dynamics, enzymatic stability, and down-stream gene expression profiles. When acquiring a Pinealon research peptide for empirical testing, investigators must demand comprehensive lot-specific documentation to confirm that observed biological interactions are attributable strictly to the target peptide sequence rather than manufacturing artifacts.
Pinealon is a synthetic short-chain bioregulatory peptide composed of three amino acids: L-glutamyl-L-aspartyl-L-arginine (EDR). With a chemical formula of C15H26N6O8 and a molecular weight of approximately 390.39 g/mol, Pinealon belongs to a class of low-molecular-weight peptides designed to cross biological membranes and interact directly with nuclear structures and chromatin complexes.
Because of its small molecular mass, synthetic synthesis via Solid-Phase Peptide Synthesis (SPPS) must be closely controlled. Errors during the coupling steps of glutamic acid, aspartic acid, or arginine can yield deletion sequences (such as Glu-Asp or Asp-Arg dipeptides) or truncated side products. Advanced analytical characterization documented in the PX1 Research library ensures that these closely related impurities are identified and quantified prior to release for laboratory evaluation.
Determining the purity of Pinealon requires a dual-assay approach combining chromatographic separation and mass verification. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) separates the primary EDR peptide from synthetic side-products, diastereomers, and degradation contaminants based on hydrophobic interaction with a stationary phase column.
A compliant Certificate of Analysis (COA) must demonstrate a clean RP-HPLC chromatogram where the main peak accounts for at least 98% of the total integrated peak area. Complementing RP-HPLC, Liquid Chromatography-Mass Spectrometry (LC-MS) confirms the exact monoisotopic mass and fragmentation pattern of the molecule. Mass spectra must display a predominant mass-to-charge (m/z) ratio corresponding strictly to the protonated EDR structure ([M+H]+ = 391.4 m/z), ruling out amino acid substitutions or heavy metal complexation.
Chemical purity alone does not guarantee suitability for delicate in vitro or in vivo model systems. Synthetic peptides derived from SPPS typically retain residual reagents, including trifluoroacetic acid (TFA) used during cleavage from the resin. High concentrations of TFA salts can alter culture medium pH and induce nonspecific cellular toxicity.
Rigorous purification protocols include counter-ion exchange (converting TFA salts to acetate or hydrochloride forms) and stringent lyophilization steps to eliminate organic solvent residues like acetonitrile and dimethylformamide (DMF). Furthermore, raw material processing must include bacterial endotoxin quantification using the Limulus Amebocyte Lysate (LAL) assay. For reliable research applications across our catalog of research peptides, endotoxin levels should remain strictly below 0.01 EU/mg to prevent immune activation in cell cultures.
Preclinical studies suggest that Pinealon acts as a chromatin-modifying bioregulatory agent. In vitro models utilizing neuronal cell populations demonstrate that short tripeptides like EDR can penetrate cell membranes, translocate to the nucleus, and selectively bind to specific histone structures and DNA promoter regions. This interaction is hypothesized to modulate gene expression related to oxidative stress response and apoptosis.
In animal models of neurodegeneration and aging, rodent studies indicate that EDR administration reduces reactive oxygen species (ROS) accumulation and preserves mitochondrial membrane potential. In vitro assay data further suggest that Pinealon upregulates expression of endogenous antioxidant enzymes, including superoxide dismutase (SOD) and glutathione peroxidase (GPx). Maintaining high purity is essential in these assays, as contaminants can confound measures of oxidative stress and transcriptomic output.
Pinealon shares structural and functional concepts with other short synthetic bioregulatory and neuroactive peptides evaluated in preclinical literature. Investigating these compounds side-by-side helps researchers map distinct pathways of gene regulation, peptide transport, and cellular protection.
For instance, while Pinealon (Glu-Asp-Arg) is evaluated primarily for neuronal chromatin interaction and ROS suppression, Epitalon (Ala-Glu-Asp-Gly) is studied for its regulatory effects on telomerase activity and pineal gland gene expression. Similarly, neuropeptides such as Semax and Selank focus on neurotrophic factor expression (such as BDNF) and neurotransmitter modulation rather than direct short-sequence gene transcription. Comparative analytical testing confirms that each sequence maintains distinct retention times and mass profiles under identical chromatographic conditions.
Lyophilized Pinealon powder exhibits high stability when stored under proper environmental conditions. Upon receipt, sealed vials should be kept desiccated at -20°C for short-term preservation or at -80°C for extended storage to prevent atmospheric moisture absorption and hydrolysis.
When reconstituting Pinealon for laboratory use, sterile, non-pyrogenic solvents such as 0.9% Bacteriostatic Sodium Chloride or sterile Phosphate-Buffered Saline (PBS, pH 7.4) are recommended. The tripeptide structure dissolves readily in aqueous media; excessive sonication or vigorous mechanical agitating should be avoided to prevent protein shearing or air entrapment. Once reconstituted, liquid aliquots should be used promptly or stored at -20°C, avoiding repeated freeze-thaw cycles that can degrade the peptide backbone.
To ensure internal experimental validity, laboratory procurement teams must rigorously audit peptide suppliers. A dependable supplier provides lot-traceable documentation generated by independent, ISO 17025 accredited analytical laboratories rather than relies on internal or unverified data sheets.
Key evaluation metrics for procurement officers include: verifying that every batch includes an independent RP-HPLC trace, confirming mass identity via LC-MS, reviewing quantitative endotoxin LAL assay results, and verifying US-based synthesis and packaging standards. Institutional accounts operating under our bulk laboratory supply program receive comprehensive multi-lot compliance certificates to streamline regulatory compliance and replicate findings across long-term research projects.
PX1 Research enforces strict quality assurance protocols to deliver high-purity compounds for scientific investigation. Every lot of Pinealon is manufactured in state-of-the-art, GMP-compliant facilities within the USA and undergoes independent testing in ISO 17025 accredited testing laboratories.
Our multi-stage verification process measures chemical purity, residual solvent clearance, TFA content, and endotoxin levels per lot. Orders ship directly from our primary facilities in California and Arizona with same-day dispatch for orders placed before cutoff times (Monday–Friday). Researchers can review complete batch analytical data anytime via our third-party COA repository to confirm product specifications prior to experiment initiation.
What is the standard chemical purity threshold for Pinealon in research applications?
PX1 Research specifies a minimum purity threshold of >98% for Pinealon, as verified by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC).
How is the molecular identity of Pinealon verified?
Identity is confirmed using Liquid Chromatography-Mass Spectrometry (LC-MS) to measure the exact monoisotopic mass (390.39 g/mol) and fragment ions corresponding to the Glu-Asp-Arg amino acid sequence.
What are the endotoxin limits for research-grade Pinealon?
Our research-grade Pinealon is tested via the Limulus Amebocyte Lysate (LAL) assay to ensure endotoxin levels remain below 0.01 EU/mg, preventing nonspecific inflammatory responses in cell culture models.
How should lyophilized Pinealon be stored upon delivery?
Lyophilized Pinealon powder should be stored desiccated at -20°C for short-term research needs or -80°C for long-term storage to prevent degradation and moisture exposure.
What solvents are suitable for reconstituting Pinealon for laboratory assays?
Pinealon dissolves readily in sterile Phosphate-Buffered Saline (PBS), 0.9% sterile saline, or sterile water for injection. The solvent choice depends on the specific requirements of the in vitro or in vivo experimental assay.
Does PX1 Research provide a Certificate of Analysis (COA) for Pinealon?
Yes. Every lot of Pinealon shipped by PX1 Research includes a lot-specific Certificate of Analysis detailing RP-HPLC purity traces, LC-MS spectra, mass verification, and endotoxin analysis from an independent ISO 17025 accredited laboratory.
What is the amino acid sequence of Pinealon?
Pinealon is a synthetic tripeptide consisting of L-glutamyl-L-aspartyl-L-arginine, often abbreviated in biological literature as Glu-Asp-Arg or EDR.
Where is PX1 Research Pinealon manufactured and shipped from?
All PX1 Research compounds are manufactured in US-based GMP-compliant facilities and shipped directly from our distribution hubs in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.